COVID-19 test kit EQ 2606-9601

for neutralizing antibodySARS-COV-2nasopharyngeal

Anti-SARS-CoV-2 NeutraLISA • - Surrogate virus neutralisation test (sVNT) for determination of neutralising antibodies that inhibit the binding of SARS-CoV-2 S1/RBD to ACE2 receptors • - Supports evaluation of the individual immune response following SARS-CoV-2 infection or vaccination with S1/RBD-based vaccines • - Very high agreement of results compared with a plaque reduction neutralisation test (PRNT50) • - Established ELISA method – automatable and suitable for routine diagnostics, no BSL-3 laboratory required • - Automatable even for high-throughput analysis, results available in 2 hours